Alternatively, DCISionRT combines immunohistochemical staining and scoring of COX2, FOXA1, HER2, Ki-67, p16/CDKN2A, PR, and SIAH2 in addition to clinical characteristics (age, tumor size, margin status, and palpability) [23]. This evidence concerns the gene CDKN2A and neoplasm.